It is possible that obesity and leptin affect only specific types of prostate cancers or only certain events during tumour progression such as epithelial/mesenchymal transition, metastasis or angiogenesis. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.